GE HealthCare Technologies (GEHC) Short-Term Debt issuances (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Short-Term Debt issuances of -$1.0 million for Q1 2026, down 200.0% on a QoQ basis from $1.0 million in Q1 2025, and down 200.0% year-over-year from $1.0 million in Q1 2025.
GE HealthCare Technologies (GEHC) Short-Term Debt issuances (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Short-Term Debt issuances history runs 5 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- Quarterly Short-Term Debt issuances fell 200.0% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Jun 2025 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.0 million, changed N/A from the prior year.
- Short-Term Debt issuances was -$1.0 million for Q1 2026 at GE HealthCare Technologies, down from $1.0 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $8.0 million in Q3 2022 and bottomed at -$9.0 million in Q1 2023.
- A 5-year average of -$250000.0 and a median of $0.0 in 2022 frame the typical range for Short-Term Debt issuances.
- Annual changes were most pronounced in 2023 — Short-Term Debt issuances tumbled 550.0% — and 2024, when it jumped 111.11%.
- GE HealthCare Technologies' Short-Term Debt issuances stood at $1.0 million in 2022, then slumped by 400.0% to -$3.0 million in 2023, then surged by 66.67% to -$1.0 million in 2024, then jumped by 200.0% to $1.0 million in 2025, then plunged by 200.0% to -$1.0 million in 2026.
- Business Quant data shows GEHC's Short-Term Debt issuances at -$1.0 million in Q1 2026, $1.0 million in Q1 2025, and -$1.0 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 31.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -164.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 12.88 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 37.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Sep 30, 2022 | 8.00 Mn |